{"raw_response": "{\"target_date\": \"2023-06-29\", \"instructions\": [{\"symbol\": \"NVDA\", \"action\": \"buy\", \"quantity\": 612, \"execution_session\": \"market_open\", \"entry_price\": 40.82, \"exit_price\": 41.23, \"exit_reason\": \"mean_reversion_target\", \"notes\": \"CONTRARIAN BUY: Model predicts -0.92% return, indicating oversold condition. Neural forecast reflects recent selling pressure - perfect setup for mean reversion bounce to +1% target.\"}, {\"symbol\": \"MSFT\", \"action\": \"buy\", \"quantity\": 247, \"execution_session\": \"market_open\", \"entry_price\": 100.93, \"exit_price\": 101.94, \"exit_reason\": \"mean_reversion_target\", \"notes\": \"CONTRARIAN BUY: Model predicts -0.54% return, signaling oversold momentum exhaustion. Fading the neural forecast for mean reversion play to +1% target.\"}], \"risk_notes\": \"Contrarian strategy assumes mean reversion after neural model extrapolates recent downtrends. Risk is if fundamental deterioration drives continued selling beyond technical oversold levels.\", \"metadata\": {\"capital_allocation_plan\": \"Deploying $49,942 (62.5% of available capital) across 2 contrarian positions. NVDA gets $24,982 (most oversold at -0.92%), MSFT gets $24,960 (moderately oversold at -0.54%). Avoiding AAPL due to positive expected return (+0.69%) indicating momentum already priced in. Keeping $30,028 cash reserve for risk management.\", \"contrarian_logic\": \"Neural networks extrapolate recent price trends. Negative forecasts = recent selling pressure = oversold bounces. Fading model predictions in -3% to -0.5% zone.\", \"expected_profit_per_trade\": \"$250 per position (1% mean reversion target minus 0.05% trading fees)\", \"total_expected_profit\": \"$500 from both positions if mean reversion thesis plays out\"}}", "model": "claude-sonnet-4-20250514", "input_tokens": 10931, "output_tokens": 563}